Company Filing History:
Years Active: 2005-2013
Title: The Innovations of Alexander Steven Whitehead
Introduction
Alexander Steven Whitehead, an accomplished inventor located in Wayne, PA, has made significant contributions to the field of medical diagnostics with a total of four patents to his name. His innovative approaches aim to enhance the understanding of drug responsiveness and folate metabolism, paving the way for personalized medicine.
Latest Patents
Whitehead's latest patents reflect his dedication to advancing healthcare. One noteworthy invention is a "Method for assessment of folate phenotypes, disease risk and response to therapy." This groundbreaking method involves measuring essential compounds like 5-methyltetrahydrofolate (5-MTHF), tetrahydrofolate (THF), and 5,10-MTHF in biological samples. The technique employs an isotope dilution liquid chromatography-multiple reaction monitoring/mass spectrometry (LC-MRM/MS) approach, showcasing a sophisticated level of scientific inquiry.
Another significant patent is titled "Methods for determining drug responsiveness." This invention provides a diagnostic assay designed to compare the mRNA levels of a gene responsive to a drug with that of a non-responsive gene. This methodology is invaluable for predicting a patient's responsiveness to medication at any stage of treatment, thus enabling more tailored therapeutic strategies.
Career Highlights
Alexander Steven Whitehead is associated with the University of Pennsylvania, where he leverages his expertise in medical research. His work demonstrates a solid commitment to innovating diagnostic methods that can significantly improve patient outcomes.
Collaborations
Throughout his career, Whitehead has collaborated with notable professionals, including Ian Blair. Together, they contribute to a collaborative research environment that supports the advancement of medical science and innovation.
Conclusion
In summary, Alexander Steven Whitehead stands out as a visionary inventor in the medical field. His patented methods not only enhance our understanding of folate metabolism and drug responsiveness but also contribute to the progress of personalized medicine. With a strong foundation in research and collaboration at the University of Pennsylvania, Whitehead continues to push the boundaries of innovation in healthcare.